Related Experiment Video
Updated: Apr 4, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.9K
Future perspective on chronic kidney disease management.
Xiaomei Qiu1, Xueqin Ding2, Henry Liu3
1Department of Anesthesiology, Chengdu First People's Hospital, Chengdu 610000, China.
Journal of Anesthesia and Translational Medicine
|April 3, 2026
Summary
Sympathetic nervous system over-activation drives chronic kidney disease (CKD) progression. Thoracic epidural blockade offers a novel therapeutic approach for CKD management, potentially overcoming limitations of current treatments.
Area of Science:
- Nephrology
- Cardiovascular Physiology
- Pain Management
Background:
- Sympathetic nervous system over-activation is a key feature of chronic kidney disease (CKD).
- Renal ischemia significantly contributes to the development and progression of CKD.
- Current pharmacologic treatments for sympathetic over-activity in CKD face challenges like limited efficacy and adverse effects.
Purpose of the Study:
- To review the pathophysiology of CKD and the role of the sympathetic nervous system.
- To evaluate the limitations of existing pharmacologic treatments and renal denervation for CKD.
- To explore thoracic epidural blockade as a novel therapeutic strategy for CKD management.
Main Methods:
- Literature review focusing on CKD pathophysiology, sympathetic nervous system involvement, and therapeutic interventions.
- Analysis of current pharmacologic strategies and renal denervation outcomes in CKD.
- Exploration of thoracic epidural blockade's potential mechanisms and benefits in CKD.
Main Results:
- Pharmacologic approaches and renal denervation show variable outcomes and risks in managing sympathetic over-activity in CKD.
- Renal denervation may disrupt essential renal nervous system regulatory functions.
- Thoracic epidural blockade presents a promising alternative by modulating sympathetic nervous system activity.
Conclusions:
- Thoracic epidural blockade offers a novel therapeutic avenue for managing sympathetic nervous system over-activation in chronic kidney disease.
- This approach may overcome the limitations associated with current pharmacologic treatments and renal denervation.
- Further research is warranted to establish the efficacy and safety of thoracic epidural blockade in CKD patients.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
627
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
627
01:18Chronic Kidney Disease IV: Nursing Management
616
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
616
01:25Chronic Kidney Disease I: Introduction
1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
01:20Acute Kidney Injury V: Interprofessional Care
480
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
480
01:24Chronic Kidney Disease II: Clinical Manifestations
964
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
964
01:29Acute Kidney Injury III: Clinical Manifestations
1.5K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K